Exam 3 Video Quiz Q & A and M12 CS Flashcards
Goal INR is between 2.0 and 3.0.
-
Fish oils increase the risk of bleeding additively with warfarin.
-
With an INR of 3.2 it’s close to range, so just hold that dose of warfarin, continue with current 5 mg of warfarin, and re-check INR in one week. If it’s high again next week, reduce his TWD by 5-10% which would be 1.75 to 3.75.
-
If patient’s INR came back >10/unreadable, what would you order for him?
- Hold warfarin and administer vitamin K
-
If the patient has ASCVD and/or a a LDLc >190 mg/dL, target LDL reduction is >50%, and use a high intensity statin.
Also if their ASCVD risk is > 7.5%.
-
Pt to receive a high intensity statin if ASCVD risk is > 7.5%.
-
If there’s no LDL baseline on a patient, get their LDL down below 70.
-
HDL > 40 is desirable.
-
TG < 150 is desirable.
-
Once your TGs get up to over 500, you run the risk of developing pancreatitis.
-
Asthma: LAMA only.
For COPD, can use both SAMA and LAMA.
-
If you have a COPD patient in the hospital for a COPD exacerbation, you would put them on oral or injectible corticosteroids, and a LAMA combined with a LABA.
Once stable, and no sx of an exacerbation, and had a hx of asthma or eosinophils >300, or in a super-sever stage, then we would add it back (ICS).
-
ICS are only for stable COPD patients (those pts not experiencing an exacerbation).
-
GOLD 2020 GUIDELINES:
- Factors to assess when considering ICS:
Strong support:
- Hospitalization for COPD exacerbation
- ≥ 2 moderate COPD exacerbations/year
- Eosinophils >300
- History/concomitant asthma
-
Are IL-5 antibodies considered a last resort for asthma treatment?
Yes or No?
Yes.